September 2026
The global plasma therapeutics market size is estimated to hit around USD 52.26 billion by 2035 increasing from USD 28.35 billion in 2025, with a CAGR of 6.31%.
September 2026
The global plasma protein therapeutics market size is projected to cross around USD 48.43 billion by 2034 from USD 32.66 billion in 2026 with a CAGR of 5.06%.
September 2026
The psoriatic arthritis therapeutics drugs market is growing with rising demand for biologics, biosimilars, and advanced targeted treatment options.
September 2026
The next-generation RNA therapeutics market is growing with innovations in RNA-based drugs, improving treatments for cancer, genetic diseases, and infectious conditions.
September 2026
The global bispecific antibody therapeutics contract manufacturing market size was evaluated at USD 13.4 billion in 2026 and is predicted to hit around USD 218.92 billion by 2035, growing at a CAGR of 36.4%.
September 2026
The global cold plasma market size is evaluated at USD 3.75 billion in 2026 and is projected to surpass around USD 12.19 billion by 2035, with a CAGR of 14.03%.
September 2026
The Canada plasma fractionation market size was evaluated at USD 1.07 billion in 2026 and is predicted to hit around USD 1.99 billion by 2035, growing at a CAGR of 7.02%.
September 2026
The global maternal health therapeutics market size was evaluated at USD 5.07 billion in 2026 and is predicted to hit around USD 9.64 billion by 2035, growing at a CAGR of 7.40%.
September 2026
The global plasma fractionation market size surpassed USD 35.82 billion in 2026 and is estimated to reach around USD 66.18 billion by 2035 with a CAGR of 7.04%.
September 2026
The Europe urinary incontinence therapeutics market was valued at USD 12.14 billion in 2026 and is expected to expand at a CAGR of 3.15% from 2026 to 2035. Research by Deepa Pandey, Senior Research Analyst.
September 2026
The anti-inflammatory therapeutics market size was estimated at USD 113.58 billion in 2026 and is expected to hit USD 164.44 billion by 2035, with a CAGR of 4.14%.
September 2026
The plasma pulse technology market size is calculated at USD 298.02 million in 2026 and is projected to hit around USD 426.78 million by 2035 with a CAGR of 4.07%.
September 2026
The global dermatology diagnostic devices and therapeutics market size is projected to hit around USD 31.33 billion by 2035 from USD 17.03 billion in 2026, with a CAGR of 7.02%.
September 2026
The U.S. digital therapeutics market size is exhibited at USD 4.56 billion in 2026 and is predicted to surpass USD 24.09 billion by 2035 with a remarkable CAGR of 20.54%.
September 2026
The global amyloidosis therapeutics market size was valued at USD 3.44 billion in 2026 and is expected to hit around 6.92 billion by 2035, growing at a CAGR of 8.09% from 2026 to 2035.
September 2026
The global parkinsons disease therapeutics market size is estimated at USD 7.49 billion in 2026 and is projected to hit around USD 14.28 billion by 2035 with a CAGR of 7.36%.
September 2026
The mRNA vaccines and therapeutics market size reached USD 130.20Â billion in 2026 and is projected to surpass around USD 297.84 billion by 2035 with a CAGR of 9.81%.
September 2026
The global esophageal cancer therapeutics market size was evaluated at USD 3.51 billion in 2026 and is predicted to hit around USD 7.75 billion by 2035, growing at a CAGR of 9.22%.
September 2026
The lung cancer therapeutics market size totalled USD 38.23 billion in 2026, with major lung cancer therapeutics market players including AstraZeneca, BoehringerIngelheim, Bristol-Myers Squibb Company, Eli Lilly and Company, Hoffmann-La Roche, Merck & Co, Pfizer Inc.
September 2026
The microbiome therapeutics market size reached USD 334.16 million in 2026, with leading microbiome therapeutics market companies including Seres Therapeutics, Nestlé Health Science, Finch Therapeutics.
September 2026
The global bacterial therapeutics market is growing as microbiome-based treatments gain traction in healthcare and biotechnology.
September 2026
The homecare diagnostics & therapeutics market size accounted for USD 291.51 billion in 2026 and is expected to hit USD 577.56 billion by 2035, with a CAGR of 7.90%.
September 2026
The global cancer therapeutics market size was evaluated at USD 232.14 billion in 2026 and is expected to surpass around USD 501.07 billion by 2035 with a CAGR of 8.95%.
September 2026
The pruritus therapeutics market size stood at USD 12.26 billion in 2026, with major pruritus therapeutics market companies including Bristol-Myers Squibb, Novartis AGÂ , Pfizer Inc.,Teva Pharmaceuticals.
September 2026
The infectious disease therapeutics market size is calculated at USD 37.67 billion in 2026 and is expected to hit around USD 53.48 billion by 2035 at a CAGR of 3.97%.
September 2026
The plasma derived therapy market size is accounted at USD 25.01 billion in 2026 and is expected to hit around USD 45.29 billion by 2035 with a CAGR of 6.83%.
September 2026
The mRNA therapeutics market size was valued at USD 22.30 billion in 2026 and is expected to hit around USD 45.40 billion by 2035, growing at a CAGR of 8.1%.
September 2026
The global scleroderma therapeutics market size is projected to surpass around USD 4.48 billion by 2035 increasing from USD 2.88 billion in 2026, with a CAGR of 5.04%.
September 2026
The remote plasma sources market size was USD 2.10 billion in 2026, with leading remote plasma sources market players including Advanced Energy Industries, Inc., MKS Instruments, Inc., Samco Inc.
September 2026
The global small interfering RNA (siRNA) therapeutics market size is estimated to hit around USD 528.78 billion by 2035 increasing from USD 214.41 billion in 2026, with a CAGR of 10.55%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com